UA117673C2 - Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти) - Google Patents

Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти)

Info

Publication number
UA117673C2
UA117673C2 UAA201507907A UAA201507907A UA117673C2 UA 117673 C2 UA117673 C2 UA 117673C2 UA A201507907 A UAA201507907 A UA A201507907A UA A201507907 A UAA201507907 A UA A201507907A UA 117673 C2 UA117673 C2 UA 117673C2
Authority
UA
Ukraine
Prior art keywords
methods
polymyxins
compositions
making
сн2сн3
Prior art date
Application number
UAA201507907A
Other languages
English (en)
Ukrainian (uk)
Inventor
Сьольві Гуннес
Відар Бьйонстад
Торбен Кох
Клес Меландер
Мартін Монссон
Original Assignee
Кселлія Фармасьютікалз Апс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кселлія Фармасьютікалз Апс filed Critical Кселлія Фармасьютікалз Апс
Publication of UA117673C2 publication Critical patent/UA117673C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
UAA201507907A 2013-01-11 2014-01-09 Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти) UA117673C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751341P 2013-01-11 2013-01-11
US201361904793P 2013-11-15 2013-11-15
PCT/EP2014/050320 WO2014108469A1 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Publications (1)

Publication Number Publication Date
UA117673C2 true UA117673C2 (uk) 2018-09-10

Family

ID=50101865

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201507907A UA117673C2 (uk) 2013-01-11 2014-01-09 Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти)

Country Status (20)

Country Link
US (1) US10640536B2 (enExample)
EP (1) EP2943503B1 (enExample)
JP (1) JP6316846B2 (enExample)
KR (1) KR20150107793A (enExample)
CN (1) CN104918951B (enExample)
AU (1) AU2014204873B2 (enExample)
BR (1) BR112015016548A2 (enExample)
CA (1) CA2895910C (enExample)
EA (1) EA027067B1 (enExample)
ES (1) ES2641017T3 (enExample)
HU (1) HUE034562T2 (enExample)
IL (1) IL239840A (enExample)
MX (1) MX360905B (enExample)
PT (1) PT2943503T (enExample)
RU (1) RU2015132569A (enExample)
SI (1) SI2943503T1 (enExample)
TW (1) TWI613219B (enExample)
UA (1) UA117673C2 (enExample)
WO (1) WO2014108469A1 (enExample)
ZA (1) ZA201504565B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014204873B2 (en) 2013-01-11 2017-07-06 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
TW201522364A (zh) * 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
CN106661090A (zh) 2014-07-09 2017-05-10 埃克斯利亚制药有限公司 低取代的多粘菌素以及它们的组合物
RS58792B1 (sr) 2014-10-03 2019-07-31 Xellia Pharmaceuticals Aps Inhalacioni uređaj
BR112017006848B1 (pt) 2014-10-03 2022-10-04 Xellia Pharmaceuticals Aps Composições
JP6896628B2 (ja) 2014-12-16 2021-06-30 シャンハイ ミクウルク ファーマシューティカル シーオー.エルティーディー 細菌感染症の治療のための抗微生物性ポリミキシン
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
AU2016331658B2 (en) * 2015-09-29 2021-04-01 Monash University Antimicrobial polymyxin derivative compounds
CN109996806B (zh) * 2016-12-09 2021-11-02 正大天晴药业集团股份有限公司 高效价的多黏菌素e2甲磺酸钠
WO2021150792A1 (en) 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
FR1586834A (enExample) * 1968-02-12 1970-03-06
WO1989009626A1 (en) 1988-04-07 1989-10-19 Luther Ronald B Non-thrombogenic intravascular time release catheter
WO1998020836A2 (en) 1996-11-15 1998-05-22 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
ATE322249T1 (de) 2001-05-18 2006-04-15 Chiron Corp System zur abgabe einer tobramycin-formulierung
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
JP2009513623A (ja) * 2005-10-28 2009-04-02 アーチ ファーマラブズ リミテッド 塩酸ジェムシタビンの改良された製造方法
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
AU2014204873B2 (en) 2013-01-11 2017-07-06 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
CN106661090A (zh) 2014-07-09 2017-05-10 埃克斯利亚制药有限公司 低取代的多粘菌素以及它们的组合物
BR112017006848B1 (pt) 2014-10-03 2022-10-04 Xellia Pharmaceuticals Aps Composições

Also Published As

Publication number Publication date
JP2016505007A (ja) 2016-02-18
CN104918951B (zh) 2018-03-30
WO2014108469A1 (en) 2014-07-17
MX2015008878A (es) 2015-10-30
RU2015132569A (ru) 2017-02-14
CA2895910C (en) 2021-12-21
TW201429995A (zh) 2014-08-01
US10640536B2 (en) 2020-05-05
IL239840A (en) 2017-09-28
CA2895910A1 (en) 2014-07-17
EA201591280A1 (ru) 2015-12-30
PT2943503T (pt) 2017-09-28
ZA201504565B (en) 2016-11-30
JP6316846B2 (ja) 2018-04-25
EP2943503A1 (en) 2015-11-18
MX360905B (es) 2018-11-21
CN104918951A (zh) 2015-09-16
HUE034562T2 (en) 2018-03-28
KR20150107793A (ko) 2015-09-23
AU2014204873A1 (en) 2015-07-09
SI2943503T1 (sl) 2017-11-30
TWI613219B (zh) 2018-02-01
EA027067B1 (ru) 2017-06-30
IL239840A0 (en) 2015-08-31
ES2641017T3 (es) 2017-11-07
EP2943503B1 (en) 2017-08-23
US20160002296A1 (en) 2016-01-07
BR112015016548A2 (pt) 2017-07-11
AU2014204873B2 (en) 2017-07-06

Similar Documents

Publication Publication Date Title
MX360905B (es) Polimixinas, composiciones, metodos de preparacion y metodos de uso.
CU20170164A7 (es) Compuestos n-tieno (2,3-d)pirimidinil-d-fenilalanina, método para preparar los mismos y composiciones farmacéuticas que los contienen
CY1120188T1 (el) ΠΑΡΑΓΩΓΑ ΝΑΦΘΥΡΙΔΙΝΗΣ ΧΡΗΣΙΜΑ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ ΙΝΤΕΓΚΡΙΝΗΣ αvβ6
EA201691085A1 (ru) Замещенные бензамиды и способы их применения
MY182568A (en) Quaternary ammonium compounds and their use as fuel or lubricant additives
CU24377B1 (es) Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
EA202190974A1 (ru) Противовирусные пролекарства и их наносоставы
MX351581B (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen.
ES2626555T3 (es) Pyridone amides como moduladores de canales de sodio
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
CR20170118A (es) Derivados espirodiamina como inhibidores de la aldosterona sintasa
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
WO2016077464A8 (en) Amino acid derivatives and their uses
SG10201805628TA (en) Deuterated heterocyclic compounds and their use as imaging agents
MY183646A (en) Low molecular weight amide/ester containing quaternary ammonium salts
MA38982A1 (fr) Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl
MX2016005993A (es) Anfifilos biscationicos y triscationicos como agentes antimicrobianos.
BR112018001980A2 (pt) compostos cíclicos úteis como moduladores de tnf alfa
MX2016014239A (es) Composicion limpiadora.
MX2017011978A (es) Analogos deuterados de etifoxina, sus derivados y usos de estos.
SG10201805896SA (en) PPARγ AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS
MY166229A (en) Nonwoven fabric and textile treating agent
MX2016014240A (es) Composicion limpiadora.
PH12016501343B1 (en) Emulsion composition for skin
MX2015016332A (es) Inhibidores de alk biciclicos fusionados.